127
Participants
Start Date
October 17, 2022
Primary Completion Date
October 30, 2023
Study Completion Date
January 30, 2024
Optimized bismuth quadruple therapy
Scheme that have high dosage of amoxicillin, metronidazole and omeprazole, with bismuth. The rationale of this scheme is that in Chile, amoxicillin resistance is low, clinical metronidazole is low in the doses used and the high doses ob Proton Pump Inhibitor enhanced the antimicrobial drugs
Control
Standard eradication therapy using omeprazole, clarithromycin and amoxicillin
Centro de especialidades médicas Marcoleta UC CHRISTUS, Santiago
Centro Médico UC-CHRISTUS San Joaquín, Santiago
Pontificia Universidad Catolica de Chile
OTHER